GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (OTCPK:OLYMY) » Definitions » Cyclically Adjusted PS Ratio

Olympus (Olympus) Cyclically Adjusted PS Ratio : 3.08 (As of Apr. 28, 2024)


View and export this data going back to . Start your Free Trial

What is Olympus Cyclically Adjusted PS Ratio?

As of today (2024-04-28), Olympus's current share price is $13.845. Olympus's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $4.50. Olympus's Cyclically Adjusted PS Ratio for today is 3.08.

The historical rank and industry rank for Olympus's Cyclically Adjusted PS Ratio or its related term are showing as below:

OLYMY' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.12   Med: 2.63   Max: 5.19
Current: 3.4

During the past years, Olympus's highest Cyclically Adjusted PS Ratio was 5.19. The lowest was 1.12. And the median was 2.63.

OLYMY's Cyclically Adjusted PS Ratio is ranked worse than
61.72% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs OLYMY: 3.40

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Olympus's adjusted revenue per share data for the three months ended in Dec. 2023 was $1.387. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $4.50 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Olympus Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Olympus's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Cyclically Adjusted PS Ratio Chart

Olympus Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.80 2.43 3.73 3.91 3.78

Olympus Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.86 3.78 3.66 3.08 3.19

Competitive Comparison of Olympus's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Olympus's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Olympus's Cyclically Adjusted PS Ratio falls into.



Olympus Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Olympus's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=13.845/4.5
=3.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olympus's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Olympus's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.387/106.8000*106.8000
=1.387

Current CPI (Dec. 2023) = 106.8000.

Olympus Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 1.424 95.700 1.589
201406 1.195 98.000 1.302
201409 1.278 98.500 1.386
201412 1.194 97.900 1.303
201503 1.302 97.900 1.420
201506 1.107 98.400 1.202
201509 1.265 98.500 1.372
201512 1.181 98.100 1.286
201603 1.371 97.900 1.496
201606 1.169 98.100 1.273
201609 1.292 98.000 1.408
201612 1.152 98.400 1.250
201703 1.350 98.100 1.470
201706 1.131 98.500 1.226
201709 1.302 98.800 1.407
201712 1.310 99.400 1.408
201803 1.480 99.200 1.593
201806 1.201 99.200 1.293
201809 1.314 99.900 1.405
201812 1.299 99.700 1.392
201903 1.401 99.700 1.501
201906 1.232 99.800 1.318
201909 1.392 100.100 1.485
201912 1.375 100.500 1.461
202003 1.400 100.300 1.491
202006 0.988 99.900 1.056
202009 1.324 99.900 1.415
202012 1.476 99.300 1.587
202103 1.552 99.900 1.659
202106 1.352 99.500 1.451
202109 1.364 100.100 1.455
202112 1.278 100.100 1.364
202203 1.342 101.100 1.418
202206 1.127 101.800 1.182
202209 1.231 103.100 1.275
202212 1.311 104.100 1.345
202303 1.432 104.400 1.465
202306 1.170 105.200 1.188
202309 1.253 106.200 1.260
202312 1.387 106.800 1.387

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Olympus  (OTCPK:OLYMY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Olympus Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Olympus's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus (Olympus) Business Description

Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.